Here are three key notes:
1. The company’s common stock began trading under the symbol “XTNT” on Oct. 19.
2. Xtant Medical develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets.
3. Xtant Medical recently participated in the North American Spine Society annual meeting in October and showcased its X-spine and Bacterin product portfolios at the meeting.
More articles on devices:
Soft Tissue Regeneration launches L-C Ligament clinical trial — 5 takeaways
Dr. Charles Brooker implants permanent spinal cord stimulator in Australia: 5 things to know
InVivo’s pilot study expands to 10 spinal cord injury patients — 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
